Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shima Gholizadeh

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 7, 2020
Advances and limitations of drug delivery systems formulated as eye dropsClotilde Jumelle, Shima Gholizadeh, Nasim Annabi, et al.
Drug Discovery Today|March 10, 2021
Advanced nanodelivery platforms for topical ophthalmic drug deliveryShima Gholizadeh, Ziqing Wang, Xi Chen, et al.
Urology Journal|June 11, 2010
Idiopathic hypercalciuria in children with vesico ureteral reflux and recurrent urinary tract infectionHashem Mahmoodzadeh, Ahmadali Nikibakhsh, Mohammad Karamyyar, et al.
International Journal of Pharmaceutics|October 19, 2017
PLGA-PEG nanoparticles for targeted delivery of the mTOR/PI3kinase inhibitor dactolisib to inflamed endotheliumShima Gholizadeh, Jan A A M Kamps, Wim E Hennink, et al.
BMC Bioinformatics|December 6, 2013
Status quo of annotation of human disease variantsHanka Venselaar, Franscesca Camilli, Shima Gholizadeh, et al.
Nature Reviews. Nephrology|January 14, 2015
Diverse origins of the myofibroblast—implications for kidney fibrosisLucas L Falke, Shima Gholizadeh, Roel Goldschmeding, et al.
Biosensors & Bioelectronics|January 16, 2017
Microfluidic approaches for isolation, detection, and characterization of extracellular vesicles: Current status and future directionsShima Gholizadeh, Mohamed Shehata Draz, Maryam Zarghooni, et al.
Pharmaceutical Research|March 9, 2018
Anti-GD2 Immunoliposomes for Targeted Delivery of the Survivin Inhibitor Sepantronium Bromide (YM155) to Neuroblastoma Tumor CellsShima Gholizadeh, Emmy M Dolman, Rebecca Wieriks, et al.
Aiche Journal. American Institute of Chemical Engineers|January 22, 2024
Engineering a drug eluting ocular patch for delivery and sustained release of anti-inflammatory therapeuticsXi Chen, Shima Gholizadeh, Mahsa Ghovvati, et al.
International Journal of Pharmaceutics|October 18, 2017
E-selectin targeted immunoliposomes for rapamycin delivery to activated endothelial cellsShima Gholizadeh, Ganesh Ram R Visweswaran, Gert Storm, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 7, 2020
Advances and limitations of drug delivery systems formulated as eye dropsClotilde Jumelle, Shima Gholizadeh, Nasim Annabi, et al.
Drug Discovery Today|March 10, 2021
Advanced nanodelivery platforms for topical ophthalmic drug deliveryShima Gholizadeh, Ziqing Wang, Xi Chen, et al.
Urology Journal|June 11, 2010
Idiopathic hypercalciuria in children with vesico ureteral reflux and recurrent urinary tract infectionHashem Mahmoodzadeh, Ahmadali Nikibakhsh, Mohammad Karamyyar, et al.
International Journal of Pharmaceutics|October 19, 2017
PLGA-PEG nanoparticles for targeted delivery of the mTOR/PI3kinase inhibitor dactolisib to inflamed endotheliumShima Gholizadeh, Jan A A M Kamps, Wim E Hennink, et al.
BMC Bioinformatics|December 6, 2013
Status quo of annotation of human disease variantsHanka Venselaar, Franscesca Camilli, Shima Gholizadeh, et al.
Nature Reviews. Nephrology|January 14, 2015
Diverse origins of the myofibroblast—implications for kidney fibrosisLucas L Falke, Shima Gholizadeh, Roel Goldschmeding, et al.
Biosensors & Bioelectronics|January 16, 2017
Microfluidic approaches for isolation, detection, and characterization of extracellular vesicles: Current status and future directionsShima Gholizadeh, Mohamed Shehata Draz, Maryam Zarghooni, et al.
Pharmaceutical Research|March 9, 2018
Anti-GD2 Immunoliposomes for Targeted Delivery of the Survivin Inhibitor Sepantronium Bromide (YM155) to Neuroblastoma Tumor CellsShima Gholizadeh, Emmy M Dolman, Rebecca Wieriks, et al.
Aiche Journal. American Institute of Chemical Engineers|January 22, 2024
Engineering a drug eluting ocular patch for delivery and sustained release of anti-inflammatory therapeuticsXi Chen, Shima Gholizadeh, Mahsa Ghovvati, et al.
International Journal of Pharmaceutics|October 18, 2017
E-selectin targeted immunoliposomes for rapamycin delivery to activated endothelial cellsShima Gholizadeh, Ganesh Ram R Visweswaran, Gert Storm, et al.
Pageof 2